Pharmacogenomics Ontology
Abbreviation: PharmGKB-owl
Homepage https://code.google.com/p/pharmgkb-owl/
Countries that developed this resource United States
Created in 2010
Taxonomic range
Subjects
How to cite this record FAIRsharing.org: PharmGKB-owl; Pharmacogenomics Ontology; DOI: https://doi.org/10.25504/FAIRsharing.xx2wv5; Last edited: Jan. 8, 2019, 1:29 p.m.; Last accessed: Mar 06 2021 5:42 p.m.
Record updated: Nov. 9, 2016, 1:14 p.m. by The FAIRsharing Team.
support email | feedback@pharmgkb.org |
Additional Information
Contact | Teri E. Klein |
External Links
Bioportal | http://bioportal.bioontology.org/ontologies/PHARMGKB |
No XSD schemas defined
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
Thorn CF,Klein TE,Altman RB
Methods Mol Biol 2005
View in BioPortal.
Reporting Guidelines
No guidelines defined
Terminology Artifacts
No semantic standards defined
Models and Formats
No syntax standards defined
Identifier Schemas
No identifier schema standards defined
Metrics
No metrics standards defined
PharmGKB curates primary genotype and phenotype data, annotates gene variants and gene-drug-disease relationships via literature review, and summarizes important PGx genes and drug pathways. PharmGKB collects, curates and disseminates knowledge about the impact of human genetic variation on drug responses.
This record is not implemented by any policy.
Record Maintainer
Maintains